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New modalities for non-invasive positive pressure 
ventilation: A review article 
 
Abstract 
Efficiency of non-invasive positive pressure ventilation in the treatment of respiratory 
failure has been shown in many published studies. In this review article, we introduced 
new modalities of non-invasive ventilation (NIV), clinical settings in which NIV can be 
used and a practical summary of the latest official guidelines published by the European 
Respiratory Clinical Practice. Clinical trials and review articles in four databases up to 25 
February 2018 about new modalities of non-invasive positive pressure ventilation were 
reviewed. Commonly used modalities for treatment of respiratory failure include: CPAP 
(continuous positive airway pressure) and BiPAP (bilevel positive airway pressure) or 
NIPSV (noninvasive pressure support ventilation). The limitations of the BiPAP method 
are the trigger and cycle asynchrony, inadequate volume delivery and increased respiratory 
rate. Newer methods, such as adaptive servo-ventilation, have been developed to treat 
central and complex sleep apnea and the NAVA (neutrally adjusted ventilatory assist) to 
improve the trigger and cycle asynchrony.  
In the proportional assist ventilation, unlike the pressure support ventilation, with 
increased patient effort (flow) the tidal volume increases and it prevents the increase in the 
respiratory rate and respiratory distress. High-flow nasal cannula is a non-invasive 
technique that does not provide respiratory support, but provides a mixture of oxygen to 
the patient. The use of non-invasive pursed-lip breathing ventilation in chronic obstructive 
pulmonary disease (COPD) patients reduces dyspnea (decreases respiratory rate) and 
increases blood oxygen saturation. New modalities of NIV improve patient comfort and 
patient–ventilator interactions, and are recommended in patients with respiratory failure. 
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The main cause of the mechanical ventilation is acute respiratory failure (1). 
Mechanical ventilation is performed in two ways, invasive and non-invasive ventilation. 
The mechanical ventilation of the lungs using mask is called non-invasive positive 
pressure ventilation (NIPPV) (2, 3). Evidence suggests that non-invasive ventilation 
compared to invasive positive pressure ventilation (IPPV) decreases the risk of ventilator 
associated pneumonia (VAP), sinusitis, sepsis, and ultimately reduces the rate of 
hospitalization and mortality (4). The present study aimed to represent the new modalities 




Data sources and search criteria: We searched clinical trials and review articles in four 
databases (Pubmed, the Cochrane Database of Systematic Reviews, Scopus and Magiran) 
up to February 25, 2018. 
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At first, all clinical trials, systematic reviews and review 
articles which used the entry terms "positive end-expiratory 
pressure" OR "positive-pressure ventilation" OR "positive-
pressure respiration" in title, abstract or keywords were 
included. Subsequently, the manuscripts that mentioned non-
invasive positive pressure ventilation and emphasized on 
new modalities of this procedure were selected. We also 
reviewed the reference lists of included studies to identify 
review articles related to search criteria. As well, we only 
searched Persian and English language published 
manuscripts. Two reviewers updated the abstract search. 
Ethics committee approval was not required for this review 
article. 
Study selection: We included clinical trials and review 
articles that reported indications and advantages of new 
modalities of NIPPV.  
Data extraction and quality assessment: Two authors, 
unblinded to data sources, summarized the included studies. 
Quality assessment was performed with emphasis on 
reporting a new modality on application of NIPPV and 




We included 16 clinical trials, review articles or 
systematic reviews which used the mentioned keywords in 
the title, abstract or keywords and emphasized on NIPPV 
new modalities and their clinical indications. 
Indications for non-invasive ventilation: Non-invasive 
ventilation indications are extensively increasing. One of the 
common indications of NIPPV is the COPD treatment, as 
well as the weaning of these patients from invasive 
ventilation (5, 6). 
Other non-invasive ventilation indications include: 
Asthma, upper airway obstruction, mild to moderate 
hypoxemia, central apnea or hypoventilation syndrome 
(Table 1). The exclusion criteria for NIPPV included: 
Immediate cardiac arrest, hemodynamic instability, shock, 
life threatening cardiac ischemia, dangerous arrhythmias, 
patients who do not cooperate, increased discharge and 
airway surgery. 
In cases of acute and short-term diseases, an oronasal 
mask, and in chronic and prolonged cases, a nasal mask 
should be used; and if the patient does not cooperate well, 
full face masks are recommended (4, 6, 7, 9). In NIPPV, all 
ventilation techniques are applicable, but CPAP (continuous 
positive airway pressure) and BiPAP (bilevel positive airway 
pressure) or NIPSV (noninvasive pressure support 
ventilation) + PEEP (positive end-expiratory pressure) are 
the most commonly used methods (4, 6, 7, 9). 
 
Table 1. Indications for non-invasive positive pressure 
ventilation (6-8) 
 
Strong evidence (Level A) 
Acute exacerbations of COPD 
To facilitate weaning in COPD 
Acute cardiogenic pulmonary edema (use of CPAP) 
Immunocompromised patients 
Reasonable evidence (Level B) 
Postoperative respiratory failure 
Asthma  
Not intubating patients 
Obstructive sleep apnea or obesity hypoventilation  




Upper airway obstruction 
Acute respiratory distress syndrome 
 
COPD: chronic obstructive pulmonary disease   CPAP: continuous positive 
airway pressure 
 
NIPPV setting: CPAP is used in patients with acute 
congestive heart failure and obstructive sleep apnea (OSA). 
In patients with obstructive sleep apnea, the CPAP is 
adjusted between 5 to 12 centimeters of water during sleep, 
after attaching the mask. 
BiPAP is the most commonly used mode in noninvasive 
method. In patients with COPD and other patients, after 
attaching the mask on the patient's face, the setting will be 3-
5 cm of water expiratory positive airway pressure (EPAP) 
and 5-15 cm of water inspiratory positive airway pressure 
(IPAP).  
EPAP is initially set on lower number, and like PEEP in 
case of hypoxemia, it can be set on the maximum of 10-12 
cm/H2O.  
If the patient has hypercarbia or tachypnea, the IPAP 
increases to a maximum of 20-25cm/H2O. The difference 
between the designated IPAP and the EPAP (figure 1) is 
called PS (5, 8-14)  
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Figure1. Pressure/time curves in spontaneous, continuous 
positive airway pressure (CPAP) and BiPAP, Pressure 
support (PS). Positive end expiratory pressure (PEEP), 
Inspiratory positive airway pressure (IPAP), expiratory 
positive airway pressure (EPAP) (12). 
 
Blood pressure, heart rate, respiratory rate, Paco2, PH 
and PaO2 should be monitored during NIPPV. When non-
invasive ventilation is effective, the above mentioned 
variables tend to be normal. The application rate of NIPPV 
depends on the severity of the underlying disease and the 
patient's admission and varies from one hour to 23 hours a 
day (4, 6, 9). The limitations of the CPAP method include 
the complications related to the mask situation on the face 
such as wound and necrosis of the nasal bridge resulted in 
patients’ speaking and eating (4, 6, 9) .The limitations of the 
BiPAP procedure include the complications of mask 
intolerance, eye damage, eating and talking and phlegm 
disorder, patient-ventilator asynchrony  including trigger and 
cycle asynchrony (15). 
PAV (Proportional assist ventilation): This PSV-like mode 
is a spontaneous breathing support mode. In fact, it is 
pressure controlled, patient triggered, pressure limited and 
flow cycled; however, in the case of hypercarbia, the 
ventilator feels the patient's increased sensitivity to the inhale 
flow, and, in contrast to the PS, it increases the current 
volume instead of increasing the number of respiration; 
therefore, it imitates the natural respiration pattern which 
COPD patients can tolerate much better. In this mode, 
operator sets the percentage of the assistance for the current 
volume, the percentage of flow assistance (based on 
resistance and elastance). PEEP and FIO2 should be 
adjusted. In this mode, the risk of Auto-PEEP and the 
disproportionate support level will be reduced (6, 16, 17). 
This mode is indicated in patients who had asynchrony with 
NIPSV. The advantages of this mode include better 
compatibility than NIPSV and prevention of over-assistance 
(18). 
Adaptive servo ventilation (ASV): A large proportion of 
patients with chronic heart failure may have chyne stoke 
respiration. In addition, some of them have coincidently 
OSA and CSA. An increase in CO2 can exacerbate heart 
failure. In these cases, CPAP alone cannot help. In the ASV 
mode, which was initially used to treat central apnea, it is 
possible to prevent obstructive apnea by regulating exhaust-
pressure during expiration. In this mode, the inspiratory 
pressure and PEEP are changing based on the patient's 
respiratory pattern. The use of ASV can be dangerous in 
CHF patients with sleep disorders and low EF (17-20). 
NAVA (Neurally adjusted ventilator assist): In the 
NAVA, the ventilator detects the contraction signal of the 
aperture by the EMG electrode located in the lower 
esophagus, and controls the ventilator, flow, volume and 
pressure without delay. Unlike the PAV, the patient's 
respiratory center controls all auxiliary breathing process 
from the trigger to the end of the inspiratory cycle. 
Currently, this mode has the highest degree of coordination 
in starting ventilation and maximum compatibility with the 
patient’s inspiration. Its limitation includes the necessity for 
esophageal catheter device (7, 18, 21, 22). 
AVAPS (Average volume assured pressure support) 
ventilation:  AVAPS is one of the intelligent ventilation 
modes that delivers the preset volume securely by changing 
the pressure support level. Studies have not shown the 
superiority of this mode in comparison with NIV in the 
conventional way. Its limitation includes increased 
inspiratory pressure in cases of low lung compliance. Its 
main indication was observed in COPD patients and 
hypoventilation syndrome (18, 23, 24). 
HFNC (High flow nasal cannula): HFNC is a new method 
for oxygen therapy that provides warm and humid oxygen to 
patients with special tools using the flow up to 60 liters per 
minute with FIO2=21- 100% (9, 25, 26). HFNC creates a 
low level of PEEP, reduces airway resistance, and washouts 
air chips. The benefits of HFNC are the lack of a ventilator, 
good compliance with the patient, and improve oxygenation. 
Its main disadvantage is the lack of ventilation support. The 
main indications of its application are hypoxemic respiratory 
failure, acute heart failure requiring a long NIV, and 
mechanical ventilation weaning (18). Treatment of 
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underlying diseases and oxygen are the basis of the AHRF 
treatment. Oxygen is prescribed in nasal cannulas, or face 
mask, NIV, and MV.  
The conventional oxygen rate given by the face mask or 
nasal cannula methods is the maximum of 15 liters per 
minute, which is not enough to provide oxygen for the 
hypoxic patient (27). 
Yue-nan et al. compared the effects of HFNC with humid 
oxygen and NIPPV in the treatment of acute respiratory 
failure in a review article. Eighteen papers and 3881 patients 
were examined for ICU tracheal intubation and mortality. 
There was no significant difference between HFNC and 
NIPPV; however, the amount of intubation was lower 
comparing to conventional HFNC oxygen therapy. In terms 
of mortality and duration of hospitalization in ICU, HFNC 
showed no superiority on conventional oxygen therapy and 
NIPPV (27, 28). Okuda et al. examined the effect of HFNC 
on the parameters of respiratory physiological parameters 
through esophageal balloon in 10 patients, with off, 30 L / 
min and 50 L / min methods. The volume of flow and PEEP 
increased with increased flow and decreased respiratory rate 
(20, 29). 
PLB (Pursed lips ventilation): PLB is a strategy in which 
the air exits slowly and is controlled by puckered lips during 
exhalation. PLB has indication for COPD patients who have 
dyspnea. PLB improves ventilation, slows retention of air, 
prolongs airway opening, reduces respiratory rate, reduces 
respiratory rate, outflows of old air and brings the new air 
flow to the lungs. In this method, the patient sits on the chair, 
relaxes the shoulder and neck muscles; then slowly inhales 
with the nose for 2 seconds, and exhales slowly with 
puckered lips within 4 seconds (30, 31). 
NIHFV (Non-invasive high-frequency ventilation): 
NIHFV is a relatively new mode which is more commonly 
used in non-invasive ventilation for infants. In this mode, the 
flow is less than the anatomical dead space (2ml / kg) with 
high respiration rate (80- 1600 per minute or 3-10 Hz) and 
mean airway pressure (MAP) (29, 32). 
Recommendations for using NIV for the treatment of 
acute respiratory failure based on the official ERS / ATS 
clinical practice guidelines: (4, 7, 9) 
 Bi-level NIV is a selective method in treatment of COPD 
exacerbation as well as preventing intubation in these 
patients. 
 Bi-level NIV or CPAP is recommended in patients with 
cardiogenic pulmonary edema. 
 There is insufficient evidence to suggest the use of NIV in 
asthmatic patients. 
 Early NIV is recommended for the treatment of acute 
respiratory failure in immunocompromised patients. 
 There is insufficient evidence to suggest the use of NIV in 
patients with NOVO ARF. 
 NIV is recommended for post-operative ARF. 
 NIV is suggested for end stage cancer patients with 
dyspnea. 
 NIV is recommended for the treatment of acute respiratory 
failure after chest trauma. 
 There is insufficient evidence to suggest using NIV in 
patients with pandemic viruses. 
 NIV is recommended for prevention of respiratory failure 
after extubation in high risk patients. This method should not 
be used in the treatment of respiratory distress after 
extubation. 
 NIV is recommended for the isolation of ventilators in 
patients with hypercapnic respiratory failure, but there is not 
enough evidence to support the treatment of hypoxic 
respiratory failure. 
The advantage of our study is to describe the indications 
and clinical aspects of the most important new modalities of 
NIPPV. A few clinical trials or review articles have been 
concerned on technical approaches of all new modalities of 
NIPPV, in recent years. Some studies described a number of 
these modalities according to target patients; for example, 
Masip described the indications and clinical considerations 
of CPAP and NIPSV in acute heart failure patients (22). 
Elgebaly compared intermittent positive pressure ventilation 
(IPPV) and NIPPV in the management of acute respiratory 
failure and hemodynamic parameters after open-heart 
surgery (15) and Ferreira evaluated NAVA and PSV in 
critically ill patients (24).  
In our study, we described all these new modalities 
which can be used in the conditions which sufficient human 
resources and equipment are not available, especially in 
developing countries. 
It is recommended for future researches to design and 
perform randomized clinical trials to compare the impacts of 
all of these new modalities in the different aspects of 
patients’ treatment. Furthermore, the implementation of a 
new modality of NIPPV –as an intelligent system- which can 
trigger the patient’s respiration depending on end-tidal 
carbon dioxide concentration and regulate the respiratory 
rate, automatically is suggested.  
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